All regulations
Nonrulemaking
FDA
FDA-2026-E-4538
Patent Term Application for YUVIWEL (navipegritide) Patent No. 10,835,578
Documents
2
Comments
0
Key Dates
Comment Period OpensApr 27, 2026
Documents
Keywords
CDER
Alston and Bird LLP
Ascendis Pharma Growth Disorders AS
Patent Term Application
for YUVIWEL (navipegritide)
Patent No 10835578
OPEN
Data from Regulations.gov